August 2, 2024< 1 min read

NEJM "Science behind the Study" Editorial: Kidney Disease and Antinephrin Antibodies

Don't miss the new "Science behind the Study" editorial by Jochen Reiser, MD, PhD (President, University of Texas Medical Branch), and Julie Ingelfinger, MD (Deputy Editor, New England Journal of Medicine), published July 31 in the New England Journal of Medicine to accompany the article by Hengel et al. presenting ISGD-supported research on the role of anti-nephrin autoantibodies in minimal change disease and idiopathic nephrotic syndrome. It provides a thorough and accessible explanation of the science, along with excellent illustrations of glomerular physiology and the novel hybrid immunoprecipitation technique used by the research team.

For additional information on this groundbreaking research, explore our exclusive Q&A and podcast episode with the authors.

As Dr. Reiser commented on X:

"Regulation of kidney filtration in health and disease has been an enigma — not so much anymore. We have made great strides as a field and are on our way to new treatments."

Laurel Damashek

Laurel Damashek is the Executive Director of the International Society of Glomerular Disease.

COMMENTS

Button Title

Laurel DamashekMay 25, 20247 min read

NEJM "Science behind the Study" Editorial: Kidney Disease and Antinephrin Antibodies

"Regulation of kidney filtration in health and disease has been an enigma — not so much anymore. We have made great strides as a field and are on our way to new treatments."

"Regulation of kidney filtration in health and disease has been an enigma — not so much anymore. We have made great strides as a field and are on our way to new treatments."

"Regulation of kidney filtration in health and disease has been an enigma — not so much anymore. We have made great strides as a field and are on our way to new treatments."

Laurel Damashek

COMMENTS

RELATED ARTICLES

Anti-nephrin autoantibodies in minimal change disease and idiopathic NS

FSGS and NS Research Funding Opportunities Through PRMRP

The AFFINITY Study: Seeking 20 FSGS Patients